What Prepaire Labs does

Prepaire Labs is a UAE-domiciled private biotechnology platform company headquartered in Abu Dhabi, with operations in Dubai and Boston. Founded in 2020, the company operates as an open, "white box" platform for personalized medicine and AI-driven drug discovery, integrating multi-omics data analysis with Digital Twin modeling of individual biology. Its core product offerings include HAiLO, an AI-driven drug interaction analysis platform covering thousands of drugs, nutrients, and herbal interactions; Genetiq, a biological intelligence platform that builds continuously evolving Digital Twin representations from biological, clinical, and environmental data; the MultiOmnis App Store, a marketplace for third-party biomedical applications including CRISPR and predictive algorithm tools; Peptomatics, an application for peptide-based approaches to drug addiction; and Toxifree for toxicology screening. The company also operates a BSL3 laboratory in Abu Dhabi supporting genome sequencing, Biobank storage, and iPSC reprogramming, and it launched SHIELD, a real-time biological intelligence and response platform for outbreak surveillance and autonomous threat response, as its first commercial product at ISNR Abu Dhabi in May 2026.

The company is monetizing through a hybrid revenue model that combines SaaS subscriptions (with a 30-day free trial), App Store and marketplace commissions, developer platform licensing, and professional services revenue from genome sequencing and Biobank storage. Distribution is multi-motion: a self-serve product-led growth path via app.prepaire.com/marketplace, enterprise direct sales for SHIELD targeting governments, healthcare systems, defense organizations, and humanitarian operators, and developer relations for third-party app publishers. Leadership consists of founder Carl Freer, COO Brent Pass, CSO Vicent Ribas-Ripoll, and Managing Director Adam Freer. The company employs 51-100 people and has 19 open scientific roles spanning omics, cellular systems biology, clinical/translational domains, aging and longevity, and data ontology, with offices in Boston and UAE markets served globally.

Name

Prepaire Labs

Legal name

Prepaire Labs Limited

Website

https://prepaire.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Prepaire Labs operates an open AI-powered biotech platform for personalized medicine, drug discovery, and biological threat intelligence, serving researchers, healthcare systems, governments, and developers through products including HAiLO, Genetiq Digital Twin, the MultiOmnis App Store, and SHIELD.

Ownership category

akta.pro rank

Product category

AI Drug Discovery Platform

NAICS

Software Publishers (513210), Medical and Diagnostic Laboratories (6215)

SIC

Services-Prepackaged Software (7372), Services-Medical Laboratories (8071)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF)

Keywords

• Drug discovery platform
• Biomedical AI software
• Multi-omics analytics
• Biological intelligence
• Digital twin modeling

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Platform Subscriptions: SaaS subscriptions for access to the Prepaire platform including HAiLO, Peptomatics, and other scientific applications. Offers a 30-day free trial for new users.
2. App Store / Marketplace Revenue: Revenue from third-party applications distributed through the MultiOmnis App Store, likely through revenue sharing or platform fees.
3. Developer Platform Licensing: Monetization models and in-platform rewards for developers building and deploying biomedical applications on the Prepaire platform.
4. Genome Sequencing & Biobank Services: Genome sequencing services and Biobank storage for biological samples supporting drug discovery and personalized medicine.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels7 records

Core offering

Prepaire Labs provides an open biomedical AI platform for personalized medicine and drug discovery, anchored by HAiLO for AI-driven drug interaction analysis and the MultiOmnis App Store for bioinformatics applications. The company sells subscriptions and developer licensing for its platform, genome sequencing and biobank services, and enterprise access to SHIELD, a biological intelligence and autonomous response system for governments and defense organizations.

Product overview

Prepaire Labs operates as an open platform for personalized medicine and drug discovery, built on a white box model that promotes collaboration and transparency. The core offering includes HAiLO for AI-driven drug interaction prediction, the MultiOmnis App Store for biomedical applications, and specialized apps like Toxifree for toxicology and Peptomatics for peptide-based addiction treatment. Genetiq provides biological intelligence and Digital Twin capabilities, while SHIELD represents the company's first commercial product launch - a real-time biological intelligence and response platform for outbreak surveillance and autonomous threat response. Together these products form an integrated ecosystem spanning drug discovery, disease modeling, and biological security.

Differentiator

Problem solved

Functional benefit

Brands

• Genetiq: A biological intelligence platform operated by Prepaire Labs that enables the creation of a continuously evolving computational representation of an individual's biology (Digital Twin) through the integration of biological, clinical, and environmental data.
• Peptomatics™

Products and services

• HAiLO AI-driven drug interaction analysis platform that uses machine learning to predict drug synergies and conflicts tailored to individual patient profiles, backed by a database covering thousands of drugs, nutrients, and herbal interactions. Built for biomedical researchers and pharmaceutical discovery teams.
• MultiOmnis App Store Centralized marketplace for third-party biomedical, gene-editing, and bioinformatics applications that researchers can discover, subscribe to, and integrate into their drug discovery and disease modeling workflows.
• Toxifree Toxicology screening application within the Prepaire ecosystem that supports drug discovery safety assessment and toxicology workflows for researchers.
• Peptomatics Application for combating drug addiction by targeting specific cell receptors to detoxify harmful drugs such as opioids and synthetics, enabling precise customization of peptides for tailored therapies and vaccines.
• Genetiq Biological intelligence platform that creates a continuously evolving computational representation of an individual's biology (Digital Twin) by integrating biological, clinical, and environmental data for personalized medicine.
• SHIELD Real-time biological intelligence and response platform integrating outbreak surveillance, environmental risk modeling, pathogen intelligence, Digital Twin modeling, and AI-driven autonomous response workflows for governments, healthcare systems, defense organizations, and humanitarian operators.
• Genome Sequencing and Biobank Services Genome sequencing services and secure Biobank storage for biological samples, supporting personalized therapies, efficient drug discovery, and personalized medicine development.

Quantifiable outcome

• Reduces time between signal detection and operational response for biological threats

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Partnerships

One partnership is on record.

• GenetiqcoreTechnology or IntegrationGenetiq is a biological intelligence platform operated by Prepaire Labs, enabling the creation of Digital Twin representations of individual biology through integration of biological, clinical, and environmental data. The platform represents a core product integration within Prepaire's ecosystem.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Atomwise: Atomwise applies AI to small-molecule drug discovery using structure-based design. Comparable to Prepaire on AI-driven molecular interaction analysis and drug discovery platform model, though focused on small molecules rather than multi-omics.
• Insitro: Insitro applies machine learning to drug discovery and development, integrating high-throughput biology with predictive models. Comparable to Prepaire on AI-driven drug discovery and multi-omics data strategy, with similar platform-as-partnership business model.
• Tempus AI: Tempus AI is a precision medicine platform combining multi-modal data (genomics, clinical, imaging) with AI for diagnostics and drug discovery. Comparable to Prepaire on Digital Twin, multi-omics, and clinical decision-support functionality.
• Valo Health: Valo Health is an AI-driven drug discovery company using human-centric data and computation. Comparable to Prepaire's platform model combining AI, biological data, and therapeutic development across multiple disease areas.
• Cradle Bio: Cradle uses generative AI for protein design and engineering in biotech applications. Comparable to Prepaire on AI/ML-enabled biologic design and protein engineering, particularly adjacent to Peptomatics' peptide customization concept.
• BlueDot: BlueDot provides infectious disease intelligence and outbreak surveillance using AI and global health data. Directly comparable to SHIELD's outbreak surveillance and biological threat intelligence capabilities for governments and public health authorities.
• Recursion Pharmaceuticals: Recursion is an AI/ML-driven drug discovery platform combining high-throughput wet-lab biology with computational models. Highly comparable to Prepaire's HAiLO/MultiOmnis AI-bio stack and shared focus on multi-omics data integration, though at much larger scale.
• Schrödinger: Schrödinger operates a computational chemistry and materials science platform for drug discovery. Comparable to Prepaire on AI/ML-driven molecular and drug-interaction analysis, with overlapping target customers in pharma research.
• Owkin: Owkin uses AI and federated learning on multi-omics and clinical data to accelerate drug discovery and precision medicine. Directly comparable to Prepaire's Genetiq Digital Twin and multi-omics platform positioning.

Broad incumbents

• Ginkgo Bioworks: Ginkgo Bioworks is a synthetic biology platform offering cell engineering and bio-manufacturing at scale. Comparable to Prepaire on multi-omics platform infrastructure and biological data, but much broader in scope (industrial biotech, biosecurity).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Prepaire_labs
• LinkedInlinkedin.com/company/prepaire-labs
• Instagraminstagram.com/prepaire_labs

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prepaire Labs